发明授权
US4889858A Dibenz[b,e]oxepin derivatives and pharmaceutical composition containing
the same
失效
二苯并[b,e] oxepin衍生物和含有它们的药物组合物
- 专利标题: Dibenz[b,e]oxepin derivatives and pharmaceutical composition containing the same
- 专利标题(中): 二苯并[b,e] oxepin衍生物和含有它们的药物组合物
-
申请号: US180104申请日: 1988-02-17
-
公开(公告)号: US4889858A公开(公告)日: 1989-12-26
- 发明人: Hitoshi Uno , Mikio Kurokawa , Fuminori Sato , Shunsuke Naruto , Yoshinobu Masuda
- 申请人: Hitoshi Uno , Mikio Kurokawa , Fuminori Sato , Shunsuke Naruto , Yoshinobu Masuda
- 申请人地址: JPX Osaka
- 专利权人: Dainippon Pharmaceutical Co., Ltd.
- 当前专利权人: Dainippon Pharmaceutical Co., Ltd.
- 当前专利权人地址: JPX Osaka
- 优先权: JPX61-142269 19860617
- 主分类号: C07D313/12
- IPC分类号: C07D313/12 ; C07D401/12 ; C07D409/12
摘要:
The present invention relates to compounds represented by the general formula (I): ##STR1## wherein R.sub.1 is H or methoxy, R.sub.2 is H, methoxy, OH or F, R.sub.3 is H or F, R.sub.4 is H or F at 7-, 8- or 9-position, and .circle.Ar is a benzene, thiophene or pyridine ring, provided that (i) at least two of R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are H, (ii) R.sub.2 or R.sub.3 is F when R.sub.4 is F, (iii) R.sub.1, R.sub.3 and R.sub.4 are H when R.sub.2 is methoxy or OH, (iv) R.sub.2 and R.sub.3 are not simultaneously F, and (v) R.sub.2 and R.sub.3 are H or F, and both R.sub.1 and R.sub.4 are H when .circle.Ar is a thiophene or pyridine ring, or a physiologically acceptable acid addition salt thereof. The compounds of the present invention have an excellent protective effect against cerebral anoxia and some of them have also an inhibitory effect on lipid peroxidation of mitochondrial membrane of brain and an anti-convulsant activity and are useful as an agent for prevention or treatment of cerebral diseases caused by hypoxia in mammals including human.
公开/授权文献
- US5510563A Crystallizaiton of 2,6-dimethylnaphthalene 公开/授权日:1996-04-23
信息查询